VOYA Investment Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-25,368
| Closed | -$451K | – | 2609 |
|
|
2018
Q3 | $451K | Hold |
25,368
| – | – | ﹤0.01% | 1901 |
|
|
2018
Q2 | $350K | Buy |
+25,368
| New | +$301K | ﹤0.01% | 2057 |
|
|
2017
Q2 | – | Sell |
-23,200
| Closed | -$60K | – | 2674 |
|
|
2017
Q1 | $60K | Hold |
23,200
| – | – | ﹤0.01% | 2473 |
|
|
2016
Q4 | $59K | Hold |
23,200
| – | – | ﹤0.01% | 2498 |
|
|
2016
Q3 | $72 | Hold |
23,200
| – | – | ﹤0.01% | 2509 |
|
|
2016
Q2 | $74K | Hold |
23,200
| – | – | ﹤0.01% | 2521 |
|
|
2016
Q1 | $72K | Hold |
23,200
| – | – | ﹤0.01% | 2454 |
|
|
2015
Q4 | $93K | Hold |
23,200
| – | – | ﹤0.01% | 2490 |
|
|
2015
Q3 | $106K | Hold |
23,200
| – | – | ﹤0.01% | 2478 |
|
|
2015
Q2 | $120K | Hold |
23,200
| – | – | ﹤0.01% | 2610 |
|
|
2015
Q1 | $145K | Hold |
23,200
| – | – | ﹤0.01% | 2495 |
|
|
2014
Q4 | $146K | Hold |
23,200
| – | – | ﹤0.01% | 2542 |
|
|
2014
Q3 | $141K | Hold |
23,200
| – | – | ﹤0.01% | 2569 |
|
|
2014
Q2 | $153K | Hold |
23,200
| – | – | ﹤0.01% | 2614 |
|
|
2014
Q1 | $552K | Hold |
23,200
| – | – | ﹤0.01% | 1899 |
|
|
2013
Q4 | $248K | Hold |
23,200
| – | – | ﹤0.01% | 2415 |
|
|
2013
Q3 | $309K | Hold |
23,200
| – | – | ﹤0.01% | 2273 |
|
|
2013
Q2 | $305K | Buy |
+23,200
| New | +$313K | ﹤0.01% | 2233 |
|
Other funds holding ECYT
VOYA Investment Management's ECYT Position: Q4 2018 in Review
VOYA Investment Management sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 25,368 shares — an estimated $451K sold.
VOYA Investment Management first reported a position in ECYT in Q2 2013 and held it in 18 quarters. The position peaked at $552K in Q1 2014. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.
- VOYA Investment Management reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
- VOYA Investment Management sold 25,368 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $451K.
- VOYA Investment Management first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 18 quarters.
- VOYA Investment Management's Endocyte, Inc. Common Stock position peaked at $552K in Q1 2014.
- 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.
Based on VOYA Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.